Akums Drugs And Stock Total Debt
| AKUMS Stock | 607.30 31.95 5.00% |
Akums Drugs and fundamentals help investors to digest information that contributes to Akums Drugs' financial success or failures. It also enables traders to predict the movement of Akums Stock. The fundamental analysis module provides a way to measure Akums Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akums Drugs stock.
Akums |
Akums Drugs and Company Total Debt Analysis
Akums Drugs' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Akums Drugs and has a Total Debt of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The total debt for all India stocks is 100.0% higher than that of the company.
Akums Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akums Drugs' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akums Drugs could also be used in its relative valuation, which is a method of valuing Akums Drugs by comparing valuation metrics of similar companies.Akums Drugs is currently under evaluation in total debt category among its peers.
Akums Fundamentals
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 134.21 B | ||||
| Shares Outstanding | 157.39 M | ||||
| Shares Owned By Insiders | 82.61 % | ||||
| Shares Owned By Institutions | 5.14 % | ||||
| Price To Book | 18.53 X | ||||
| Price To Sales | 3.09 X | ||||
| Revenue | 42.31 B | ||||
| EBITDA | 4.96 B | ||||
| Book Value Per Share | 49.59 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Number Of Employees | 7.39 K | ||||
| Market Capitalization | 130.91 B |
About Akums Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akums Drugs and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akums Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akums Drugs and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.